Literature DB >> 34297190

[Early diagnosis of keratoconus].

Stefan J Lang1, P Maier2, T Böhringer2, T Reinhard2.   

Abstract

Keratoconus is morphologically associated with increasing deformation, thinning and scarring of the cornea. This functionally leads to refractive changes and visual deterioration. In the early stages there are often no clear clinical signs in the slit-lamp examination; however, confirming the diagnosis as early as possible is important in order to provide patients with an appropriate treatment. For the early diagnosis of keratoconus, various diagnostic devices have been introduced in recent years and decades. These include keratometry with reflection-based or elevation-based systems and optical coherence tomography. High-frequency ultrasound microscopy and corneal biomechanics can also be used to establish the diagnosis of keratoconus by the measurement of other parameters. The necessity and the available possibilities for early diagnosis of keratoconus are presented in more detail in this article.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Corneal biomechanics; High-frequency ultrasound microscopy; Keratometry; Optical coherence tomography; Scheimpflug tomography

Mesh:

Year:  2021        PMID: 34297190     DOI: 10.1007/s00347-021-01460-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  47 in total

1.  BOLD fMRI and DTI in strabismic amblyopes following occlusion therapy.

Authors:  Shikha Gupta; Senthil S Kumaran; Rohit Saxena; Sunita Gudwani; Vimala Menon; Pradeep Sharma
Journal:  Int Ophthalmol       Date:  2015-12-12       Impact factor: 2.031

2.  Corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results.

Authors:  Peter S Hersh; Steven A Greenstein; Kristen L Fry
Journal:  J Cataract Refract Surg       Date:  2011-01       Impact factor: 3.351

3.  Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date.

Authors:  H Wagner; J T Barr; K Zadnik
Journal:  Cont Lens Anterior Eye       Date:  2007-05-03       Impact factor: 3.077

4.  A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus.

Authors:  David P S O'Brart; Elsie Chan; Konstantinos Samaras; Parul Patel; Shaheen P Shah
Journal:  Br J Ophthalmol       Date:  2011-02-24       Impact factor: 4.638

Review 5.  [Keratoconus: clinical aspects, diagnosis, therapeutic possibilities].

Authors:  J Bühren; G Bischoff; T Kohnen
Journal:  Klin Monbl Augenheilkd       Date:  2011-09-12       Impact factor: 0.700

6.  The natural history of corneal topographic progression of keratoconus after age 30 years in non-contact lens wearers.

Authors:  Akilesh Gokul; Dipika V Patel; Grant A Watters; Charles N J McGhee
Journal:  Br J Ophthalmol       Date:  2016-10-11       Impact factor: 4.638

7.  Asymmetry between Left and Right Eyes in Keratoconus Patients Increases with the Severity of the Worse Eye.

Authors:  T Eppig; C Spira-Eppig; S Goebels; B Seitz; M El-Husseiny; M Lenhart; K Papavasileiou; N Szentmáry; A Langenbucher
Journal:  Curr Eye Res       Date:  2018-03-20       Impact factor: 2.424

Review 8.  Acute corneal hydrops in keratoconus - new perspectives.

Authors:  Jennifer C Fan Gaskin; Dipika V Patel; Charles N J McGhee
Journal:  Am J Ophthalmol       Date:  2014-01-31       Impact factor: 5.258

9.  Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus.

Authors:  Stefan J Lang; Elisabeth M Messmer; Gerd Geerling; Marc J Mackert; Tobias Brunner; Sylvia Dollak; Borislav Kutchoukov; Daniel Böhringer; Thomas Reinhard; Philip Maier
Journal:  BMC Ophthalmol       Date:  2015-07-21       Impact factor: 2.209

10.  Analysis of the changes in keratoplasty indications and preferred techniques.

Authors:  Stefan J Lang; Mona Bischoff; Daniel Böhringer; Berthold Seitz; Thomas Reinhard
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.